Figure 1
Figure 1. (A) Logarithmic scale of the absolute number of nucleated cells after CD25+ immunomagnetic separation and at the end of the KT64/86-stimulated culture, of which the median proportion of CD4+CD25+ cells was 97% (range, 88-99) and with 87% (range, 78-95) expressing CD4+FoxP3+CD127–. (B) The median proportion, interquartile range, and range of CD4+FoxP3+CD127lowHelios+ cells that expressed the surface markers CD62L, OX40, and 41BB. (C) The median proportion, interquartile range, and range of chemokine receptors expression on CD4+FoxP3+CD127lowHelios+ cells; CXCR3+ (Th1-like), CXCR3–CCR6– (Th2-like), CXCR3–CCR4+CCR6+CCR10– (Th17-like), and CXCR3–CCR4+CCR6+CCR10+ (Th22-like). (D) The median proportion, interquartile range, and range of CD4+FoxP3+Helios+ cells that after ionophore and PMA stimulation expressed IFNγ, TNFα, IL-2, IL-4, IL-10, and IL-17. (E) The median proportion, interquartile range, and range of utilization of 24 v beta-chains in CD4+CD25++ cells from the Treg product. (F) The proportion of CD4+FoxP3+CD127low cells derived from the expansion product detected in the PB of the patients with an informative HLA marker (n = 7). The black lines on all panels represent the median values.

(A) Logarithmic scale of the absolute number of nucleated cells after CD25+ immunomagnetic separation and at the end of the KT64/86-stimulated culture, of which the median proportion of CD4+CD25+ cells was 97% (range, 88-99) and with 87% (range, 78-95) expressing CD4+FoxP3+CD127. (B) The median proportion, interquartile range, and range of CD4+FoxP3+CD127lowHelios+ cells that expressed the surface markers CD62L, OX40, and 41BB. (C) The median proportion, interquartile range, and range of chemokine receptors expression on CD4+FoxP3+CD127lowHelios+ cells; CXCR3+ (Th1-like), CXCR3CCR6 (Th2-like), CXCR3CCR4+CCR6+CCR10 (Th17-like), and CXCR3CCR4+CCR6+CCR10+ (Th22-like). (D) The median proportion, interquartile range, and range of CD4+FoxP3+Helios+ cells that after ionophore and PMA stimulation expressed IFNγ, TNFα, IL-2, IL-4, IL-10, and IL-17. (E) The median proportion, interquartile range, and range of utilization of 24 v beta-chains in CD4+CD25++ cells from the Treg product. (F) The proportion of CD4+FoxP3+CD127low cells derived from the expansion product detected in the PB of the patients with an informative HLA marker (n = 7). The black lines on all panels represent the median values.

Close Modal

or Create an Account

Close Modal
Close Modal